TANGO THERAPEUTICS, INC.

Insiders Tango Therapeutics, Inc.

Equities

TNGX

US87583X1090

Market Closed - Nasdaq Other stock markets 01:30:00 18/06/2024 am IST			5-day change	1st Jan Change
9.38 ^USD	+5.04%		+31.01%	-5.25%

11/06	Transcript : Tango Therapeutics, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 02:40 PM
28/05	HC Wainwright Adjusts Price Target on Tango Therapeutics to $13 From $17, Maintains Buy Rating	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

British billionaire Joe Lewis fined $5 million by US judge for insider trading	05/04	RE
Multibillionaire Joe Lewis to face US sentencing for insider trading	04/04	RE
British billionaire Joe Lewis intends to plead guilty to US charges, lawyer says	24/01	RE
Tango Therapeutics, Inc. Announces Board Changes	08/11	CI
Tango Therapeutics, Inc. Announces Board Changes	30/23/30	CI
Tango Therapeutics, Inc. Announces Alan Huang, Ph.D., the Company's Chief Scientific Officer, Intends to Transition Out of His Role as Chief Scientific Officer	07/23/07	CI
Tango Therapeutics, Inc. Announces the Appointment of Adam Crystal, M.D., Ph.D. as President of Research and Development	28/23/28	CI
Tango Therapeutics, Inc. Appoints Aaron Weitzman as Chief Medical Officer	10/22/10	CI
Tango Therapeutics Appoints Dr. Michael Palmieri as Head of CMC	24/22/24	CI
Tango Therapeutics Announces Appointment of Dr. Marc Rudoltz as Chief Medical Officer	01/21/01	CI
BCTG Acquisition Corp. Announces Executive Resignations	14/21/14	CI
BCTG Acquisition Corp. Appoints James B. Avery to the Board as a Class 3 Director	07/20/07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer